Статья

ScreenPro FH - Screening Project for Familial Hypercholesterolemia in Central, Southern and Eastern Europe: Rationale and Design

Richard ČeškaThird Department of Medicine -Department of Endocrinology and Metabolism of the First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech RepublicGyörgy ParaghInstitute of Internal Medicine, University of Debrecen Faculty of Medicine, Debrecen, HungaryŽeljko ReinerDepartment of Internal Medicine, Division of Metabolic Diseases, School of Medicine University of Zagreb, University Hospital Centre Zagreb, Zagreb, CroatiaMaciej BanachDepartment of Hypertension, Medical University of Lodz, Lodz, PolandLâle TokgözoğluDepartment of Cardiology, Hacettepe University Faculty of Medicine, Ankara, TurkeyAndrey V. SusekovDepartment of clinical Pharmacology and therapeutics, Academy for Postgraduate Education, Ministry of Health, Russian FederationKatarı́na RašlováCoordination Centre for Familial Hyperlipidemias, Slovak Medical University, Bratislava, SlovakiaTomáš FreibergerMedical Faculty, Masaryk University, Brno, Czech RepublicBranislav VohnoutCoordination Centre for Familial Hyperlipidemias, Slovak Medical University, Bratislava, SlovakiaAndrzej RynkiewiczDepartment of Cardiology and Cardiosurgery, Faculty of Medical Sciences, University of Warmia and Mazury, Olsztyn, PolandAssen GoudevQueen Giovanna University Hospital, Sofia, BulgariaDan Gheorghe-AndreiUniversity of Medicine Carol Davila, Colentina University Hospital, Bucharest, RomaniaDan GaițăUniversity of Medicine & Pharmacy Victor Babes, Institute of Cardiovascular Diseases, CardioPrevent Foundation Timisoara, RomaniaBelma PojskićCantonal hospital, Zenica, Bosnia and HerzegovinaIvan PećinDepartment of Internal Medicine, Division of Metabolic Diseases, School of Medicine University of Zagreb, University Hospital Centre Zagreb, Zagreb, CroatiaMeral KayıkçıoğluCardiology Department, Ege University Medical School, Lipid Clinic, Izmir, TurkeyOlena MitchenkoМ. В. ЕжовRussian Cardiology Research and Production Centre, Moscow, Russian FederationGustavs LatkovskisLatvian Institute of Cardiology and Regenerative Medicine, Faculty of Medicine, University of Latvia; Paul Stradins Clinical University Hospital, Riga, LatviaŽaneta PetrulionienėCentre of Cardiology and Angiology, Vilnius University Hospital Santariskiu Klinikos, Vilnius, LithuaniaZlatko FrasDivision of Internal Medicine, Preventive Cardiology Unit and Medical Faculty, University of Ljubljana, University Medical Centre, Ljubljana, SloveniaNebojša TasićCardiovascular Research Centre, Cardiovascular Institute "Dedinje", Belgrade, SerbiaErkin М МirrakhimovNational Centre of Cardiology and Therapy named after academician Mirsaid Mirrakhimov, Kyrgyz State Medical Academy naved after I. K. Akhunbaev, Bishkek, KyrgyzstanT. M. MuratalievNational Centre of Cardiology and Therapy named after academician Mirsaid Mirrakhimov, Kyrgyz State Medical Academy naved after I. K. Akhunbaev, Bishkek, KyrgyzstanAlexander B. ShekRepublican Specialized Centre of Cardiology, Tashkent, UzbekistanVladimír TukaThird Department of Medicine -Department of Endocrinology and Metabolism of the First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech RepublicAlexandros D. TselepisDepartment of Chemistry, University of Ioannina, Atherothrombosis Research Centre, Ioannina, GreeceElie MoubarakKhalid Al‐RasadiCollege of Medicine and Health Science at Sultan Qaboos University, Sultan Qaboos University Hospital, Muscat, Oman

Vnitřní lékařstvíjournal2017en

ABI

Аннотация

Familial hypercholesterolemia (FH) is a genetic disorder with well-known genetic transmission and clinical course. Despite great recent progress, FH is still underestimated, under-diagnosed and thus undertreated. Furthermore it represents a significant healthcare challenge as a common risk factor for the premature development of coronary heart disease. The ScreenPro FH Project is an international network project aiming at improving complex care - from timely screening, through diagnosis to up-to-date treatment of familial hypercholesterolemia in Central, Eastern and Southern Europe. An important task for the project is to harmonise and unify diagnostic and therapeutic approaches in participating countries, where the situation differs from country to country. Countries with more experience should serve as a model for countries developing the FH network.Key words: diagnosis - familial hypercholesterolemia - screening - treatment optimization.

Перевод пока недоступен

Темы

Lipoproteins and Cardiovascular Health Cancer, Lipids, and Metabolism Diabetes, Cardiovascular Risks, and Lipoproteins

Идентификаторы

DOI: 10.36290/vnl.2017.008

Цитирования и источники

Цитирований: 0Использованных источников: 24

Показатели — AkademScholar · Скоро